ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

July 26, 1985

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

New research Suggested For Immunobiology

November 18, 1977